InvestLog
SXTC China SXT Pharmaceuticals, Inc. logo

SXTC China SXT Pharmaceuticals, Inc.

Healthcare
$1.66+1.22%ClosedMarket Cap: $1.3M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.20

P/S

1.41

EV/EBITDA

9.21

DCF Value

$35.82

FCF Yield

-77.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

25.5%

Operating Margin

-224.1%

Net Margin

-274.4%

ROE

-14.7%

ROA

-9.5%

ROIC

-9.5%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 null$455.7K$-1.3M$—
FY null$1.7M$-3.3M$—
Q3 null$455.7K$-1.3M$—
Q2 null$414.7K$-401.3K$—

Trading Activity

Insider Trades

View All
Zhou Feng Felixdirector, officer: Co-CEO and Director
SellMon Apr 27
Zheng Jundirector:
SellMon Apr 27
Simon Lim Sze Bengofficer
SellMon Apr 27
Pan Xiaodong Seanofficer
SellMon Apr 27
Liu Tong Tonydirector:
SellMon Apr 27

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

CN

Exchange

—

Beta

1.96

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

Peers

ATLN logoATLNAVR logoAVRCYBN logoCYBNFATE logoFATEIPHA logoIPHAIXHL logoIXHLMIST logoMISTNVCT logoNVCTSAVA logoSAVATNXP logoTNXP